StockData
Octave Specialty Group Inc logo

Octave Specialty Group Inc (OSG) stock

OSGNYSESurety InsuranceFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.95−0.37 (-6.95%)

Close on Nov 17, 2026Market cap $223.01MP/E –Yield –

Octave Specialty operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Octave Specialty's operating cash flow for the twelve months ending Jun 30, 2026 was -$62.13M. For fiscal 2025 it was -$52.28M, down 6961.3% from the year before. The highest annual figure on record is $830.31M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$52.28M-6961.3%
FY2024Dec 31, 2024$762.00K-97.9%
FY2023Dec 31, 2023$36.95M-47.5%
FY2022Dec 31, 2022$70.37M–
FY2021Dec 31, 2021-$131.00M–
FY2020Dec 31, 2020-$175.00M–
FY2019Dec 31, 2019-$311.00M–
FY2018Dec 31, 2018-$1.54B–
FY2017Dec 31, 2017-$221.00M-126.6%
FY2016Dec 31, 2016$830.31M–
FY2012Dec 31, 2012-$613.90M-17358.9%
FY2011Dec 31, 2011$3.56M–
FY2010Dec 31, 2010-$2.09B–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.23M-576.1%
Q1 FY2026Mar 31, 2026-$10.08M–
Q4 FY2025Dec 31, 2025-$666.00K–
Q3 FY2025Sep 30, 2025-$41.15M-184.1%
Q2 FY2025Jun 30, 2025$2.15M-89.5%
Q1 FY2025Mar 31, 2025-$12.61M-278.4%
Q4 FY2024Dec 31, 2024-$75.63M–
Q3 FY2024Sep 30, 2024$48.91M+344.7%
Q2 FY2024Jun 30, 2024$20.41M-15.0%
Q1 FY2024Mar 31, 2024$7.07M-90.8%
Q4 FY2023Dec 31, 2023-$75.05M-760.2%
Q3 FY2023Sep 30, 2023$11.00M-77.1%
Q2 FY2023Jun 30, 2023$24.00M+1100.0%
Q1 FY2023Mar 31, 2023$77.00M+755.6%
Q4 FY2022Dec 31, 2022$11.37M+127.4%
Q3 FY2022Sep 30, 2022$48.00M–
Q2 FY2022Jun 30, 2022$2.00M–
Q1 FY2022Mar 31, 2022$9.00M–
Q4 FY2021Dec 31, 2021$5.00M–
Q3 FY2021Sep 30, 2021-$53.00M-312.0%
Q2 FY2021Jun 30, 2021-$43.00M–
Q1 FY2021Mar 31, 2021-$40.00M–
Q4 FY2020Dec 31, 2020-$88.00M–
Q3 FY2020Mar 31, 2020$25.00M–
Q4 FY2019Dec 31, 2019-$15.00M–
Q3 FY2019Sep 30, 2019-$31.00M–
Q2 FY2019Jun 30, 2019-$170.00M–
Q1 FY2019Mar 31, 2019-$95.00M–
Q4 FY2018Dec 31, 2018-$125.06M–
Q3 FY2018Sep 30, 2018-$106.36M–
Q2 FY2018Jun 30, 2018-$120.03M–
Q1 FY2018Mar 31, 2018-$1.19B–

More Octave Specialty figures

See a number that looks wrong?